latest updates

  • As a CRO service provider, Creative Biolabs focuses on developing novel therapeutic antibody programs, with the help of our partners, to fight cancer. We guarantee every step of the program is original, unique, and to your satisfaction. Our team will try our best to move the progress forward. We believe the high degree of collaboration will help with project developments, compared with the current CRO service pattern. This anti-CD48 monoclonal antibody program aims to develop therapeutic mAb against CD48 expressed on tumor cells. Learn more about Next-IO™ Anti-CD48 Monoclonal Antibody Program: https://www.creative-biolabs.com/immuno-oncology/anti-cd48-monoclonal-antibody-program.htm
  • cataliesw
  • Creative Biolabs has been a long-term expert in the field of next-generation probiotics (NGPs). Based on our deep understanding of Clostridium butyricum, our scientists will build up best-fit solutions to develop C. butyricum as probiotics for our global customers' specific requirements. Learn more: https://live-biotherapeutic.creative-biolabs.com/clostridium-butyricum.htm
  • cataliesw
  • Recombinant humanized (from mouse) antibody expressed in CHO binding to human CD37. Otlertuzumab is a humanized monoclonal antibody designed for the treatment of cancer. Learn more: https://www.creativebiolabs.net/Anti-Human-CD37-Therapeutic-Antibody-Otlertuzumab-13754.htm
  • cataliesw
  • For a decade, Creative Biolabs is dedicated to providing antibody engineering services to many clients in need. Empowered by our comprehensive platforms and portfolios, our scientists are at the top in the field and experience in discovering and developing novel therapeutic. Next-IO™ Anti-CD94/NKG2A Monoclonal Antibody Program aims to develop novel therapeutic antibody candidates for cancer patients in need. Learn more: https://www.creative-biolabs.com/immuno-oncology/anti-cd94-nkg2a-monoclonal-antibody-program.htm
  • cataliesw
  • ADCC-Enhanced Biobetter is a class of therapeutic biological antibodies that are not fucosylated. Creative Biolabs has an advanced Afuco™ technology platform that can control the glycosylation level of antibodies, achieving ADCC enhancement by reducing fucosylation in the Fc region of the antibody. This class of antibodies is a biological drug that increases the binding affinity of the FcyR receptor to immune effector cells. More specifically, DNA recombinant technology is used to produce this fucosylated therapeutic ADCC-Enhanced. It is produced in CHO cells lacking fucosylation and purified by affinity chromatography of protein G. Learn more about ADCC-enhanced Biobetters: https://adcc.creative-biolabs.com/category-adcc-enhanced-biobetters-357.htm
  • cataliesw
  • Monkeypox Virus Antigen Rapid Test Kit is designed for detecting MPXV antigen in plasma, serum or whole blood samples. This product is furnished for research use only. Not for diagnostic or therapeutic use. Learn more about rapid monkeypox test: https://monkeypox.creative-biolabs.com/monkeypox-virus-antigen-rapid-test-ruo-36.htm
  • cataliesw
  • With advantages in various aspects, peptides have great potential in immune checkpoint drug development. During the development of immune checkpoint targeted peptide, peptide design is the beginning of the whole process. As an experienced CRO company with robust foundations, Creative Biolabs will be your best partner. With a mature technique system and comprehensive drug development platforms, Creative Biolabs has accomplished hundreds of customer-satisfied projects. Learn more: https://immune-checkpoint.creative-biolabs.com/immune-checkpoint-targeted-peptide-design.htm
  • cataliesw
  • When displayed on the surface of exosomes, these molecules show increased solubility/functionality and can be used for a wide range of applications, including drug discovery, ligand screening, and targeted drug delivery. Creative Biolabs utilizes this technology, termed exosome display, for different research purposes and to promote clinical applications. Learn more: https://www.creative-biolabs.com/exosome/exosome-display.htm
  • cataliesw
  • Cancer vaccines consist of one or more antigenic components, including live-attenuated or killed viral or bacterial particles, proteins, polysaccharides, polynucleotides, and particle conjugates. Additionally, other excipients like adjuvants may be present. Not only the chemical and structural integrity of various components must be maintained, but the immunogenicity must be ensured. Thus, the complexity of vaccines creates a unique challenge for characterization. Learn more about GMP cancer vaccine analysis: https://www.creative-biolabs.com/car-t/gmp-cancer-vaccine-analysis-and-qualification.htm
  • cataliesw
  • Mesenchymal stem cells (MSC) have received significant attention in recent years with regard to their suitability for use in cellular therapies due to their high growth potential and multipotential differentiation capacity. As a trusted research partner in the field of biotherapeutics, Creative Biolabs provides cutting-edge cell therapy research services covering every stage of MSC development, including isolation, expansion, characterization, and differentiation. Learn more about mesenchymal stem cell research: https://www.creative-biolabs.com/stem-cell-therapy/mesenchymal-stem-cells-mscs-services.htm
  • cataliesw
  • Macrophages play an important role in cancer development and metastasis. Proinflammatory M1 macrophages can target cancerous cells, and therefore, can be engineered as drug carriers for tumor therapy. As a leading specialist in engineering macrophages, Creative Biolabs provides comprehensive R&D services of engineering M1 macrophages, macrophage-derived exosomes, and macrophage membrane as drug carriers. Learn more about Engineering Macrophage for Drug Delivery: https://macrophage.creative-biolabs.com/macrophage-engineering-service-for-drug-delivery.htm
  • cataliesw
  • SEEDbody represents a groundbreaking fusion protein built on the innovative Fc analogue platform, leveraging the strand-exchange engineered domain (SEED) technique. SEED is a humanized CH3 domain, comprising alternating segments of human IgG and IgA CH3 sequences, forming complementary heterodimers. Learn more about SEEDbody Generation: https://www.creative-biolabs.com/bsab/overview-of-seedbody.htm
  • cataliesw
  • Particulate matter (PM), especially particulates with diameters of less than 2.5 mm, can penetrate the alveolar region and increase the risk of respiratory diseases. The proven adverse health effects of PM have stimulated various research efforts to develop methods for its detection. With years of research and development experience in phage display technology, Creative Biolabs has a group of scientists who are proficient in identifying binding-peptide with high specificity and affinity to particulate matter. We can provide the best service of identification of PM binding peptide at the most competitive cost. Learn more about Particulate Matter Binding Peptides Identification: https://www.creative-biolabs.com/particulate-matter-binding-peptides-identification-service.html
  • cataliesw
  • Immune checkpoints are regulators to enhance or moderate immune responses. Immune checkpoint mechanisms are often activated to suppress the nascent anti-tumor immune response, which leads to the development of several immune checkpoint inhibitors, such as antibodies, peptides, and small molecular drugs for cancer therapy. Learn more about ICI research: https://immune-checkpoint.creative-biolabs.com/services.htm
  • cataliesw
  • During years of exploration in neural differentiation models, Creative Biolabs has developed a comprehensive technology platform with a variety of available models. Our platform is now equipped with advanced facilities, experienced experts, and the latest technologies. With these strong foundations, we are confident in offering custom dopaminergic neurons differentiation model services to global clients. Learn more about ipsc derived dopaminergic neurons: https://neurost.creative-biolabs.com/dopaminergic-neurons-differentiation-service.htm

age: 25
member since: Oct 12, 2023

cataliesw's widget

0 following